Concurrent EPOR::IGH fusion gene and numerous cytoplasmic granules in BCR::ABL1-like B-lymphoblastic leukemia

被引:1
|
作者
Long, Fang [1 ]
Bai, Mingming [2 ]
Zheng, Fan [2 ]
Li, Ting [3 ,5 ]
Zhang, Xiaohui [2 ,4 ]
机构
[1] Chengdu Med Coll, Sichuan Prov Matern & Child Hlth Care Hosp, Affiliated Womens & Childrens Hosp, Dept Clin Lab, Chengdu, Sichuan, Peoples R China
[2] Shijiazhuang Pingan Hosp, Dept Expt Diagnost, Shijiazhuang, Hebei, Peoples R China
[3] Beijing Ludaopei Hosp, Dept Lab Med, Beijing, Peoples R China
[4] Shijiazhuang Pingan Hosp, Dept Expt Diagnost, 48 Cangfeng Rd, Shijiazhuang 050021, Hebei, Peoples R China
[5] Beijing Ludaopei Hosp, Dept Lab Med, 22 Tongji South Rd,Yizhuang Econ Technol Dev Area, Beijing 100176, Peoples R China
关键词
D O I
10.1002/pbc.30908
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Pseudo-Chediak-Higashi inclusions in BCR::ABL1-like B-lymphoblastic leukemia with IGH::EPOR rearrangement
    Nedumannil, Rithin
    Juneja, Surender
    BLOOD, 2022, 139 (10) : 1598 - 1598
  • [2] From the archives of MD Anderson Cancer Center: BCR-ABL1-like B acute lymphoblastic leukemia with IGH/EPOR fusion
    Liu, Wei
    Thakral, Beenu
    Tang, Guilin
    Wang, Wei
    Medeiros, L. Jeffrey
    Konoplev, Sergej
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 46
  • [3] BCR::ABL1-Like B-Cell Acute Lymphoblastic Leukemia with BCR::PDGFRA Fusion: A Case Report and Literature Review
    Hua, Jiamin
    Yan, Han
    Qian, Xiangyu
    Gao, Dongyan
    Yang, Bo
    Xu, Yubing
    Li, Jianfeng
    Weng, Xiangqin
    Zhu, Yongmei
    Wang, Jin
    ACTA HAEMATOLOGICA, 2024, 147 (04) : 467 - 474
  • [4] BCR/ABL1-like acute lymphoblastic leukemia: How to diagnose and treat?
    Chiaretti, Sabina
    Messina, Monica
    Foa, Robin
    CANCER, 2019, 125 (02) : 194 - 204
  • [5] Mutational Profile of B-Lymphoblastic Leukemia with BCR::ABL1
    Lai, Xiaoxuan
    Hu, Collin
    Tang, Guilin
    Fang, Hong
    Wang, Wei
    Patel, Keyur
    You, M. James
    Medeiros, L. Jeffrey
    Hu, Shimin
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1438 - S1438
  • [6] BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1?
    Takahashi, Taro
    Ichikawa, Satoshi
    Ichinohasama, Ryo
    Harigae, Hideo
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1265 - 1267
  • [7] Outcomes of BCR::ABL1-like B-Lineage Acute Lymphoblastic Leukemia in the Era of Novel Therapies
    Youshanlouei, Hamed Rahmani
    Shah, Syed
    Anazco, Francisca
    Patel, Anand Ashwin
    Duvall, Adam S.
    Roloff, Gregory W.
    Drazer, Michael W.
    Kosuri, Satyajit
    Nawas, Mariam T.
    Lager, Angela
    Fitzpatrick, Carrie
    Wang, Peng
    Tjota, Melissa
    Gurbuxani, Sandeep
    Cheng, Jason Xiaojun
    Segal, Jeremy
    Odenike, Olatoyosi
    Larson, Richard A.
    Stock, Wendy
    Venkataraman, Girish
    Saygin, Caner
    BLOOD, 2024, 144 : 5918 - 5919
  • [8] Laboratory testing in BCR-ABL1-like (Philadelphia-like) B-lymphoblastic leukemia/lymphoma
    Siegele, Bradford J.
    Nardi, Valentina
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 971 - 977
  • [9] BCR-ABL1-like B-lymphoblastic leukemia/lymphoma: Review of the entity and detection methodologies
    Conant, Joanna L.
    Czuchlewski, David R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 126 - 130
  • [10] MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia
    Kaumeyer, Benjamin
    Fidai, Shiraz
    Sukhanova, Madina
    Yap, Kai Lee
    Segal, Jeremy
    Raca, Gordana
    Stock, Wendy
    McNeer, Jennifer
    Lager, Angela M.
    Gurbuxani, Sandeep
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1436 - 1444